Diary - News All news Medesis Pharma and Transgene collaborate to explore the contribution of the Aonys® platform

Medesis Pharma and Transgene collaborate to explore the contribution of the Aonys® platform

Medesis Pharma and Transgene collaborate to explore the contribution of the Aonys® platform to oncolytic virotherapies

July 8, 2019 – MEDESIS PHARMA announces the signing of a collaborative research agreement with TRANSGENE to apply Aonys® technology to the treatment of tumors by oncolytic viruses. This collaboration allows testing of an innovative approach of modulating the tumoral microenvironment, and thus increasing the oncolytic viruses’ activity and their field of use.